Moneycontrol
HomeNewsIndiaCOVID-19 vaccine | Over 206 crore doses administered in India so far

COVID-19 vaccine | Over 206 crore doses administered in India so far

Those aged 60 years and above have so far been administered 3.44 crore precaution doses of the coronavirus vaccine.

August 06, 2022 / 21:38 IST
Story continues below Advertisement
Representative image

The cumulative COVID-19 vaccine doses administered in the country crossed 206 crore with over 24 lakh jabs administered on Saturday till 7 pm, the Union Health Ministry said. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late at night.

With 17,51,960 precaution doses being administered to those aged 18-59 years on Saturday till 7 pm, the tally of such jabs given in this age group so far has crossed 5,22,88,707, according to Health Ministry data. Those aged 60 years and above have so far been administered 3.44 crore precaution doses.

Story continues below Advertisement

So far, over 3.94 crore children aged 12 to 14 years have been administered the first dose while more than 6.13 crore adolescents between 15 and 18 years have been given the first dose. A special 75-day drive to administer precaution doses free of cost to all aged 18 years and above at government vaccination centres is underway.

The 'COVID Vaccination Amrit Mahotsava' drive which started on July 15 to boost the uptake of Covid precaution doses among the eligible population, is being held as part of the government's Azadi Ka Amrit Mahotsav to celebrate the 75th anniversary of India's Independence. The countrywide vaccination drive was rolled out on January 16 last year with healthcare workers getting inoculated in the first phase. Vaccination of frontline workers started from February 2 last year.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show